Market open
Portage Biotech Inc/$PRTG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Portage Biotech Inc
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Ticker
$PRTG
Sector
Trading on
Industry
Biotechnology
Headquarters
Tortola, Virgin Islands, British
Employees
7
ISIN
VGG7185A1369
Website
PRTG Metrics
BasicAdvanced
$13M
-
-$63.79
1.46
-
Price and volume
Market cap
$13M
Beta
1.46
52-week high
$15.82
52-week low
$3.92
Average daily volume
1.7M
Financial strength
Current ratio
3.077
Quick ratio
2.674
Total debt to equity
4.029
Interest coverage (TTM)
-367.44%
Management effectiveness
Return on assets (TTM)
-15.45%
Return on equity (TTM)
-198.89%
Valuation
Price to book
6.35
Price to tangible book (TTM)
6.35
Price to free cash flow (TTM)
-0.856
Growth
Earnings per share change (TTM)
-50.69%
3-year earnings per share growth (CAGR)
28.35%
PRTG News
AllArticlesVideos
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
GlobeNewsWire·2 weeks ago
Why Is Portage Biotech Stock Skyrocketing Friday?
Benzinga·2 months ago
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Portage Biotech Inc stock?
Portage Biotech Inc (PRTG) has a market cap of $13M as of May 14, 2025.
What is the P/E ratio for Portage Biotech Inc stock?
The price to earnings (P/E) ratio for Portage Biotech Inc (PRTG) stock is 0 as of May 14, 2025.
Does Portage Biotech Inc stock pay dividends?
No, Portage Biotech Inc (PRTG) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Portage Biotech Inc dividend payment date?
Portage Biotech Inc (PRTG) stock does not pay dividends to its shareholders.
What is the beta indicator for Portage Biotech Inc?
Portage Biotech Inc (PRTG) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.